Stay updated on Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Sign up to get notified when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. No user-facing content appears to be changed.
    Difference
    0.0%
    Check dated 2026-03-11T18:05:24.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown. The previously displayed notices about government funding lapse (v3.4.1) have been removed.
    Difference
    0.3%
    Check dated 2026-02-11T04:43:06.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now shows an administrative notice about a lapse in government funding and an updated revision tag (v3.4.1) replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T03:28:40.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The update adds a glossary display option and updates several page labels and revision text, for example 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older labels like 'No FEAR Act Data' are removed.
    Difference
    0.2%
    Check dated 2026-01-28T00:35:28.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; this minor version change does not affect page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:15:35.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section with a Texas site; removed the Texas Locations section and the HHS Vulnerability Disclosure link, and updated the revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T10:22:31.000Z thumbnail image

Stay in the know with updates to Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.